Determination of the Relative Toxicity of Amphotericin B Formulations: A Red Blood Cell Potassium Release Assay

REFERENCES

• Adler-Moore, J. P., and R. T. Proffitt. 1993. Development, characterization, effi- cacy and mode of action of AmBisome, a unilamellar liposomal formulation of amphotericin B. J. Liposome Res. 3:429–450.
   Google Scholar
• Anaissie, E., V. Paetznick, R. Proffitt, J. Adler-Moore, and G. P. Bodey. 1991. Comparison of the in vitro antifunga l activity of free and liposome- encapsulated amphotericin B. Eur. J. Clin. Microbiol. Infect. Dis. 10: 665-668.Anhert-Hilger, G., G. S. Chhatwal, H.-J. Hessler, and E. Habermann. 1982. Changes in erythrocyt e permeability due to palytoxin as compared to amphotericin B. Biochim. Biophys. Acta 688:486 -494.
   Google Scholar
• Bhamra, R., A. Sa’ad, L. E. Bolcsak, A. S. Janoff, and C. E. Swenson. 1997. Behavior of amphotericin B lipid complex in plasma in vitro and in the cir- culation of rats. Antimicrob. Agents Chemother. 41:886–892.
   PubMed Web of Science ®Google Scholar
• Brajtburg, J., W. G. Powderly, G. S. Kobayashi, and G. Medoff. 1990. Ampho- tericin B: Current understandin g of mechanism s of action. Antimicrob. Agents Chemother. 34:183–188.
   PubMed Web of Science ®Google Scholar
• Butler, W. T., and E. Cotlove. 1971. Increased permeability of human erythro- cytes induced by amphotericin B. J. Infect. Dis. 123:341– 350.
   PubMed Web of Science ®Google Scholar
• De Kruijff, B., W. J. Gerritsen, A. Oerlemans, R. A. Demel, and L. L. M.
   Google Scholar
• Van Deenen. 1974. Polyene antibiotic-sterol interactions in membrane s of Acholeplasma laidwalii cells and lecithin liposomes II: Temperature depen- dence of the polyene antibiotic-sterol complex formation. Biochim. Biophys. Acta 339:30- 43.
   Web of Science ®Google Scholar
• Fujii, G. 1996. Liposomal amphotericin B (AmBisome): Realization of the drug delivery concept. In Vesicles, ed. M. Rostoff, 491–526. New York: Marcel Dekker.
   Google Scholar
• Fujii, G., J.-E. Chang, T. Coley, and B. Steere. 1997. The formation of ampho- tericin B ion channels in lipid bilayers. Biochemistry 36:4959– 4968.
   PubMed Web of Science ®Google Scholar
• Gale, E. F. 1974. The release of potassium ions from Candida albicans in the presence of polyene antibiotics. J. Gen. Microbiol. 80:451–465.
   PubMedGoogle Scholar
• Gruda, I., E. Gauthier, S. Elberg, J. Brajtburg, and G. Medoff. 1988. Effects of the detergen t sucrose monolaurat e on binding of amphoterici n B to sterols and its toxicity for cells. Biochem. Biophys. Res. Commun. 154:954–958.
   PubMed Web of Science ®Google Scholar
• Gruda, I., D. Milette, M. Brother, G. S. Kobayashi, G. Medoff, and J. Brajtburg. 1991. Structure-activity study of inhibition of amphoterici n B (Fungizone) binding to sterols, toxicity to cells, and lethality to mice by esters of sucrose. Antimicrob. Agents Chemother. 35:24–28.
   PubMed Web of Science ®Google Scholar
• Guo, L. S. S., R. M. Fielding, D. D. Lasic, R. L. Hamilton, and D. Mufson. 1991. Novel antifunga l drug delivery: Stable amphotericin B-cholesteryl sulfate discs Int. J. Pharm. 75:45–54.
   Google Scholar
• Hiemenz, J. W., and T. J. Walsh. 1996. Lipid formulations of amphoterici n B: Recent progress and future directions. Clin. Infect. Dis. 22(suppl. 2): S133-S144.
   Google Scholar
• Janknegt, R., S. de Marie, I. A. J. M. Bakker-Woudenberg, and D. J. A. Crommelin. 1992. Liposomal and lipid formulations of amphoterici n B: Clin- ical pharmacokinetics. Clin. Pharmacokinet. 23:279–291.
   PubMed Web of Science ®Google Scholar
• Janoff, A. S., L. T. Boni, M. C. Popescu, S. R. Minchey, P. R. Cullis, T. D. Madden, T. Taraschi, S. M. Gruner, E. Shyamsunder, M. W. Tate, R. Mendelsohn, and D. Bonner. 1988. Unusual lipid structures selectively reduce the toxicity of amphoterici n B. Proc. Natl. Acad. Sci. USA 85:6122– 6126.
   PubMed Web of Science ®Google Scholar
• Joly, V., P. Aubry, A. Ndayiragide, I. Carriere, E. Kawa, N. Mlika-Cabanne,
   Google Scholar
• J. P. Aboulker, J. P. Coulaud, B. Larouze, and P. Yeni. 1996. Randomized comparison of amphotericin B deoxycholat e dissolved in dextrose or intralipid for the treatment of AIDS-associated cryptococca l meningitis. Clin. Infect. Dis. 23:556–562.
   PubMedGoogle Scholar
• Khutorsky, V. E. 1992. Structures of amphoterici n B-cholesterol complex. Biochim. Biophys. Acta 1108:123–127.
   PubMed Web of Science ®Google Scholar
• Kirsh, R., R. Goldstein, J. Tarloff, D. Parris, J. Hook, N. Hanna, P. Bugelski, and G. Poste. 1988. An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasis. J. Infect. Dis. 158:1065–1070.
   Google Scholar
• Kotler-Brajtburg, J., G. Medoff, G. S. Kobayashi, S. Boggs, D. Schlessinger,
   Google Scholar
• R. C. Pandey, and K. L. Rinehart, Jr. 1979. Classification of polyene antibiotics according to chemical structure and biological effects. Antimicrob. Agents Chemother. 15:716–722.
   PubMed Web of Science ®Google Scholar
• Moreau, P., N. Milpied, N. Fayette, J.-F. Ramee, and J.-L. Harousseau. 1992. Re- duced renal toxicity and improved clinical tolerance of amphoterici n B mixed with intralipid with conventiona l amphoterici n B in neutropeni c patients J. Antimicrob. Chemother. 30:535–541.
   Google Scholar
• Perkins, W. R., S. R. Mincey, L. T. Boni, C. E. Swenson, M. C. Popescu, R. F. Pasternack, and A. S. Janoff. 1992. Amphotericin B-phospholipi d interactions responsibl e for reduced mammalian cell toxicity. Biochim. Biophys. Acta 1107:271–282.
   PubMed Web of Science ®Google Scholar
• Proffitt, R. T., A. Satorius, S.-M. Chiang, L. Sullivan, and J. P. Adler-Moore. 1991. Pharmacology and toxicology of a liposomal formulation of am- photericin B (AmBisome) in rodents. J. Antimicrob. Chemother. 28B:49- 61.
   Google Scholar
• Readio, J. D., and R. Bittman. 1983. Equilibrium binding of amphoterici n B and its methyl ester and borate complex to sterols. Biochim. Biophys. Acta 685:219– 224.
   Web of Science ®Google Scholar
• Sievers, T. M., B. M. Kubak, and A. Wong-Beringer. 1996. Safety and efficacy of intralipid emulsions of amphotericin B. J. Antimicrob. Chemother. 38:333- 347.
   Web of Science ®Google Scholar
• Steinberg, B. A., W. P. Jambor, and L. O. Suydam. 1956. Amphotericin s A and B: Two new antifungal antibiotics possessing high activity against deep-seated and superficial mycoses. Antibiot. Annu. 1955-1956:574 -578.
   Google Scholar
• Van Hoogevest, P., and B. De Kruijff. 1978. Effect of amphoterici n B on cholesterol-containin g liposomes of egg phosphatidylcholin e and dido- cosenoylphosphatidycholine. Biochim. Biophys. Acta 511:397– 407.
   PubMedGoogle Scholar
• Vertut-Croquin, A., J. Bolard, M. Chabbert, and C. Gary-Bobo. 1983. Dif- ferences in the interaction of the polyene antibiotic amphoterici n B with cholesterol - or ergosterol-containin g phospholipi d vesicles. A circular dichro- ism and permeability study. Biochemistry 22:2939– 2944.
   PubMed Web of Science ®Google Scholar
• Warnock, D. W. 1991. Amphoterici n B: An introduction. J. Antimicrob. Chemother. 28B:27-38.
   Google Scholar